Price Alert

Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

9.46

-0.61 (-6.06%)

At close: Sep 25, 2025, 3:59 PM

9.57

1.16%

After-hours: Sep 25, 2025, 04:19 PM EDT

-6.06% (1D)

Bid	9.45
Market Cap	245.98M
Revenue (ttm)	1.03M
Net Income (ttm)	-36.26M
EPS (ttm)	-0.68
PE Ratio (ttm)	-13.91
Forward PE	-2.76
Analyst	Buy
Dividends	n/a

Ask	10.1
Volume	100,537
Avg. Volume (20D)	77,756
Open	9.83
Previous Close	10.07
Day's Range	9.41 - 9.99
52-Week Range	8.46 - 26.50
Beta	0.39
Ex-Dividend Date	n/a

About RNAC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RNAC

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RNAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Cartesian Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+21.86%

Cartesian Therapeutics shares are trading higher a... Unlock content with Pro Subscription

News

2 weeks ago · seekingalpha.com

Cartesian Therapeutics, Inc. (RNAC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cartesian Therapeutics, Inc. (NASDAQ:RNAC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT Company Participants Carsten Brunn - President, CEO & Director Milos M...

1 month ago · fool.com

Cartesian (RNAC) Q2 Revenue Drops 99%

2 months ago · zacks.com

Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last?

Cartesian Therapeutics, Inc. (RNAC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further...